Bristol-Myers Squibb CompanySEC Filings
|
|
All SEC filings by Bristol-Myers Squibb Company (BMY) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 30, 2026 | |
| 10-Q | Quarterly report | View Diff | Apr 30, 2026 | |
| ARS | Annual report to shareholders | Mar 25, 2026 | ||
| 10-K | Annual report | View Diff | Feb 11, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 30, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 31, 2025 | |
| 10-Q | Quarterly report | View Diff | Apr 24, 2025 | |
| ARS | Annual report to shareholders | Mar 26, 2025 | ||
| 10-K | Annual report | View Diff | Feb 12, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 31, 2024 |
Events
| 8-K | Bristol Myers Squibb Reports Second Quarter Financial Results for 2026 and Raises Full-Year Outlook | Jul 30, 2026 | ||
| 8-K | Submission of Matters to a Vote of Security Holders | May 8, 2026 | ||
| 8-K | Bristol Myers Squibb Reports First Quarter Financial Results for 2026 | Apr 30, 2026 | ||
| 8-K | Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025 | Feb 5, 2026 | ||
| 8-K | Regulation Fd Disclosure | Jan 12, 2026 | ||
| 8-K | Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers | Nov 18, 2025 | ||
| 8-K | Other Events | Nov 10, 2025 | ||
| 8-K | Bristol Myers Squibb Announces Cash Tender Offers to Purchase | Nov 3, 2025 | ||
| 8-K | Bristol Myers Squibb Reports Third Quarter Financial Results for 2025 | Oct 30, 2025 | ||
| 8-K | Bristol Myers Squibb Reports Second Quarter Financial Results for 2025 | Jul 31, 2025 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | May 8, 2026 | ||
| 15-12G | Securities registration termination | Mar 27, 2026 | ||
| 8-A12B | Registration of securities on exchange | Nov 10, 2025 | ||
| 424B5 | Prospectus supplement for primary offering | Nov 7, 2025 | ||
| FWP | Free writing prospectus | Nov 5, 2025 | ||
| 424B2 | Prospectus for primary offering | Nov 3, 2025 | ||
| POSASR | Automatic shelf registration (post-effective amendment) | Oct 31, 2025 | ||
| 25-NSE | Exchange delisting | May 15, 2025 | ||
| SC TO-T/A | Third party tender offer statement | May 13, 2025 | ||
| SC TO-T/A | Third party tender offer statement | May 6, 2025 |
Proxies
| DEFA14A | Merger / Business Combination | Apr 17, 2026 | ||
| DEFA14A | Annual Meeting | Mar 25, 2026 | ||
| DEF 14A | Annual Meeting of Shareholders | View Diff | Mar 25, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 15, 2025 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 26, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 26, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 22, 2024 | ||
| DEFA14A | Additional proxy soliciting materials | Mar 28, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 28, 2024 | |
| PRE 14A | Preliminary proxy | Mar 18, 2024 |
Other
| CERT | Certification of approval for exchange listing | Nov 12, 2025 | ||
| CORRESP | Correspondence with SEC | Feb 16, 2024 | ||
| UPLOAD | Letter from SEC | Apr 8, 2022 | ||
| CORRESP | Correspondence with SEC | Apr 6, 2022 | ||
| CORRESP | Correspondence with SEC | Jan 18, 2022 | ||
| UPLOAD | Letter from SEC | Dec 16, 2021 | ||
| UPLOAD | Letter from SEC | Feb 1, 2021 | ||
| CORRESP | Correspondence with SEC | Jan 6, 2021 | ||
| UPLOAD | Letter from SEC | Dec 22, 2020 | ||
| EFFECT | Notice of effectiveness | Jun 16, 2020 |
Ownership
| 4 | Gallman Cari | Oct 5, 2026 | ||
| 4 | Yale Phyllis R | Oct 2, 2026 | ||
| 4 | Samuels Theodore R. Ii | Oct 2, 2026 | ||
| 4 | Rice Derica W | Oct 2, 2026 | ||
| 4 | Mcmullen Michael R. | Oct 2, 2026 | ||
| 4 | Arduini Peter J | Oct 2, 2026 | ||
| 4 | Massacesi Cristian | Sep 10, 2026 | ||
| 144 | Notice of proposed sale of securities | Sep 9, 2026 | ||
| 4 | Short Bartie Wendy | Sep 3, 2026 | ||
| 4 | Holzer Phil M | Aug 26, 2026 |